Contáctenos
Acerca de la compañía
Starton Therapeutics is a biotechnology company focused on transforming the standard of care therapeutics. The company develops a transdermal patch technology created to transform chemotherapy-induced nausea and vomiting. It uses proven transdermal technology with proprietary drivers to obtain new indications or develop on-label superiority for patients with hematological malignancies. Starton Therapeutics was established in 2017 and is headquartered in New York.
US
Desconocido
Empresa no verificada
Transparencia empresarial
- No verificó la información de la empresa
- Pide reseñas a sus clientes
- No respondió a las críticas negativas.